Eugene Lottering's Biography

Eugene Lottering, CEO, Msizi Pharmaceutical Holdings

Education Background:

Medical Microbiology and Immunology – University of Louisville (Ky).

Diploma – IMD, Lausanne, Switzerland.

MD of Specpharm Holdings (Pty) Ltd for 10 years; a start-up company transformed from a factory into a vertically integrated pharmaceutical company.

CEO, of the National Innovation Fund for 10-years prior.

Commercialization of a One Step Continuous Synthesis of Flucytosine

Thursday, 17 March 2022 at 17:15

Add to Calendar ▼2022-03-17 17:15:002022-03-17 18:15:00Europe/LondonCommercialization of a One Step Continuous Synthesis of FlucytosineInnovations in API Manufacture 2022 in BostonBostonSELECTBIOenquiries@selectbiosciences.com

The one-step continuous flow synthesis technology for the manufacture of Flucytosine was developed and prototyped in Europe. It is being transferred to South Africa by Msizi Pharmaceutical Holdings (Pty) Ltd a start-up API manufacturing company. Flucytosine is an important anti-fungal that is unavailable in the majority of African countries. However, it is also a key intermediate in the manufacture of some Anti-retroviral APIs currently used in South Africa and on the African continent. Continuous manufacturing via flow chemistry provides South Africa with an opportunity to localize the manufacture of Essential medicine APIs.

Add to Calendar ▼2022-03-17 00:00:002022-03-18 00:00:00Europe/LondonInnovations in API Manufacture 2022Innovations in API Manufacture 2022 in BostonBostonSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors